ArticleSubstance abuse2012
Medication-assisted treatment in criminal justice agencies affiliated with the criminal justice-drug abuse treatment studies (CJ-DATS): availability, barriers, and intentions.
Article in Substance abuse, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
118 citing papers in PubMed, 3 syntheses or guidelines pooled it, 222 citations in OpenAlex.
- A call to action: Contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated.Preventive medicine · 2023Pooled it
- Opioid-related treatment, interventions, and outcomes among incarcerated persons: A systematic review.PLoS medicine · 2019Pooled it
- Pharmacotherapy for opioid addiction in community corrections.International review of psychiatry (Abingdon, England) · 2018Pooled it
- Assessing the comparative effectiveness of ECHO and coaching implementation strategies in a jail/provider MOUD implementation trial.Implementation science : IS · 2025Trial
- Examining use of telehealth in jails: linking women to community OUD services.BMC women's health · 2024Trial
- Using structured implementation interventions to improve referral to substance use treatment among justice-involved youth: Findings from a multisite cluster randomized trial.Journal of substance abuse treatment · 2022Trial
- Stepped-wedge randomized controlled trial of a novel opioid court to improve identification of need and linkage to medications for opioid use disorder treatment for court-involved adults.Journal of substance abuse treatment · 2021Trial
- Impact of extended release naltrexone on health-related quality of life in individuals with legal involvement and opioid use disorders.Substance abuse · 2021Trial
- Longitudinal analysis of HIV-risk behaviors of participants in a randomized trial of prison-initiated buprenorphine.Addiction science & clinical practice · 2019Trial
- Do patient characteristics moderate the effect of extended-release naltrexone (XR-NTX) for opioid use disorder?Journal of substance abuse treatment · 2018Trial
- Initiation of extended release naltrexone (XR-NTX) for opioid use disorder prior to release from prison.Journal of substance abuse treatment · 2018Trial
- Assessing informed consent in an opioid relapse prevention study with adults under current or recent criminal justice supervision.Journal of substance abuse treatment · 2017Trial
- A randomized clinical trial of buprenorphine for prisoners: Findings at 12-months post-release.Drug and alcohol dependence · 2017Trial
- Extended-release naltrexone for pre-release prisoners: A randomized trial of medical mobile treatment.Contemporary clinical trials · 2017Trial
- Injectable pharmacotherapy for opioid use disorders (IPOD).Contemporary clinical trials · 2016Trial
- Effects of an Organizational Linkage Intervention on Inter-Organizational Service Coordination Between Probation/Parole Agencies and Community Treatment Providers.Administration and policy in mental health · 2016Trial
- Extended-release naltrexone to prevent relapse among opioid dependent, criminal justice system involved adults: rationale and design of a randomized controlled effectiveness trial.Contemporary clinical trials · 2015Trial
- Effect of an organizational linkage intervention on staff perceptions of medication-assisted treatment and referral intentions in community corrections.Journal of substance abuse treatment · 2015Trial
- Feasibility and Effectiveness of Continuing Methadone Maintenance Treatment During Incarceration Compared With Forced Withdrawal.Journal of addiction medicineTrial
- Statewide implementation of MOUD in jails: aligning barriers and strategies in the quest for acceptability and feasibility.Health & justice · 2026Article
58 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors at 10 institutions in 2 countries.
Funding
Abstract
Medication-assisted treatment (MAT) is underutilized in the treatment of drug-dependent, criminal justice populations. This study surveyed criminal justice agencies affiliated with the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) to assess use of MAT and factors influencing use of MAT. A convenience sample (N = 50) of criminal justice agency respondents (e.g., jails, prisons, parole/probation, and drug courts) completed a survey on MAT practices and attitudes. Pregnant women and individuals experiencing withdrawal were most likely to receive MAT for opiate dependence in jail or prison, whereas those reentering the community from jail or prison were the least likely to receive MAT. Factors influencing use of MAT included criminal justice preferences for drug-free treatment, limited knowledge of the benefits of MAT, security concerns, regulations prohibiting use of MAT for certain agencies, and lack of qualified medical staff. Differences across agency type in the factors influencing use and perceptions of MAT were also examined. MAT use is largely limited to detoxification and maintenance of pregnant women in criminal justice settings. Use of MAT during the community reentry period is minimal. Addressing inadequate knowledge and negative attitudes about MAT may increase its adoption, but better linkages to community pharmacotherapy during the reentry period might overcome other issues, including security, liability, staffing, and regulatory concerns. The CJ-DATS collaborative MAT implementation study to address inadequate knowledge, attitudes, and linkage will be described.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.